Genome-engineering technologies for modeling and treatment of cystic fibrosis
Advances in Medical Sciences · 2023
DOI: 10.1016/j.advms.2023.02.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Medical Sciences, 2023. Verfasst von Michał Dębczyński und 5 weiteren Autor:innen. Beteiligte Einrichtung: II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland. Electronic address: michal.debczynski@umb.edu.pl. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: Medical University of Bialystok.
Abstract (Originalsprache)
Cystic fibrosis (CF) is an autosomal recessive disease caused by defects in the CF transmembrane conductance regulator (CFTR) protein. Due to the genetic nature of the disease, interventions in the genome can target any underlying alterations and potentially provide permanent disease resolution. The current development of gene-editing tools, such as designer nuclease technology capable of genome correction, holds great promise for both CF and other genetic diseases. In recent years, Cas9-based technologies have enabled the generation of genetically defined human stem cell and disease models based on induced pluripotent stem cells (iPSC). In this article, we outline the potential and possibilities of using CRISPR/Cas9-based gene-editing technology in CF modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland. Electronic address: michal.debczynski@umb.edu.pl.
- II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland.
- II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland; Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland; Department of Psychiat…
Förderung
- Medical University of Bialystok
Zitieren
APA
Dębczyński, M., Mojsak, D., Minarowski, Ł., Maciejewska, M., Lisowski, P., & Mróz, R. M. (2023). Genome-engineering technologies for modeling and treatment of cystic fibrosis. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2023.02.003
Vancouver
Dębczyński M, Mojsak D, Minarowski Ł, Maciejewska M, Lisowski P, Mróz RM. Genome-engineering technologies for modeling and treatment of cystic fibrosis. Advances in Medical Sciences. 2023. doi:10.1016/j.advms.2023.02.003
BibTeX
@article{Dbczyski2023,
author = {Dębczyński, Michał and Mojsak, Damian and Minarowski, Łukasz and Maciejewska, Monika and Lisowski, Paweł and Mróz, Robert M},
title = {Genome-engineering technologies for modeling and treatment of cystic fibrosis},
journal = {Advances in Medical Sciences},
year = {2023},
doi = {10.1016/j.advms.2023.02.003}
}
EUVIMED